Physician profile
Euiyoung Chong
NPI 1831677244
$6,628.12
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.35 · 2020: $157 · 2021: $5,364 · 2022: $123 · 2023: $743 · 2024: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720 · Education: $175 · Consulting Fee: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.57 |
| Education | $175.00 |
| Consulting Fee | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $5,279.48 | 2020-2021 | |
| Zimvie INC. | $364.77 | 2022-2024 | |
| Biolase, INC. | $297.41 | 2023 | Waterlase Iplus |
| Align Technology, INC. | $197.20 | 2019-2024 | Invisalign, Itero Element 5d Plus Lite |
| Straumann USA LLC | $178.16 | 2023 | |
| Orapharma, A Division of Bausch Health US, LLC | $130.92 | 2021 | |
| Dentsply Sirona INC | $71.72 | 2020-2021 | |
| Nobel Biocare USA | $52.43 | 2023 | Nobelactive |
| Colgate Oral Pharmaceuticals, INC. | $27.25 | 2024 | |
| Kulzer, LLC | $15.88 | 2021 | |
| Gc America INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Euiyoung Chong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.